On the Role of Dendritic Cells Versus Other Cells in Inducing Protective CD8+ T Cell Responses

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2014 Feb 28

PMID 24575091

Citations 12

Authors

Rolf Martin Zinkernagel

Affiliations

Soon will be listed here.

Citing Articles

Self-Assembling Protein Nanoparticles in the Design of Vaccines: 2022 Update.

Morales-Hernandez S, Ugidos-Damboriena N, Lopez-Sagaseta J Vaccines (Basel). 2022; 10(9).

PMID: 36146525 PMC: 9505534. DOI: 10.3390/vaccines10091447.

Persons who inject drugs (PWID) retain functional NK cells, dendritic cell stimulation, and adaptive immune recall responses despite prolonged opioid use.

Tomescu C, Colon K, Smith P, Taylor M, Azzoni L, Metzger D J Leukoc Biol. 2020; .

PMID: 33289158 PMC: 8244827. DOI: 10.1002/JLB.5A0920-604R.

The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients.

Pollack S Expert Rev Vaccines. 2017; 17(2):107-114.

PMID: 29280411 PMC: 6521962. DOI: 10.1080/14760584.2018.1419068.

Effective Priming of Herpes Simplex Virus-Specific CD8 T Cells Does Not Require Infected Dendritic Cells.

Whitney P, Makhlouf C, MacLeod B, Ma J, Gressier E, Greyer M J Virol. 2017; 92(3).

PMID: 29142130 PMC: 5774880. DOI: 10.1128/JVI.01508-17.

First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient.

Pollack S, Lu H, Gnjatic S, Somaiah N, OMalley R, Jones R J Immunother. 2017; 40(8):302-306.

PMID: 28891906 PMC: 5733794. DOI: 10.1097/CJI.0000000000000183.

References

Ochsenbein A, Klenerman P, Karrer U, Ludewig B, Pericin M, Hengartner H . Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A. 1999; 96(5):2233-8. PMC: 26766. DOI: 10.1073/pnas.96.5.2233. View

Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

Ochsenbein A, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J . Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature. 2001; 411(6841):1058-64. DOI: 10.1038/35082583. View

Pericin M, Althage A, Freigang S, Hengartner H, Rolland E, Dupraz P . Allogeneic beta-islet cells correct diabetes and resist immune rejection. Proc Natl Acad Sci U S A. 2002; 99(12):8203-6. PMC: 123045. DOI: 10.1073/pnas.122241299. View

Ohashi P, Oehen S, BUERKI K, Pircher H, Ohashi C, Odermatt B . Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 1991; 65(2):305-17. DOI: 10.1016/0092-8674(91)90164-t. View

Kundig T, Bachmann M, DiPaolo C, Simard J, Battegay M, Lother H . Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science. 1995; 268(5215):1343-7. DOI: 10.1126/science.7761853. View

Zinkernagel R . On cross-priming of MHC class I-specific CTL: rule or exception?. Eur J Immunol. 2002; 32(9):2385-92. DOI: 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V. View

Ludewig B, Maloy K, Lopez-Macias C, Odermatt B, Hengartner H, Zinkernagel R . Induction of optimal anti-viral neutralizing B cell responses by dendritic cells requires transport and release of virus particles in secondary lymphoid organs. Eur J Immunol. 1999; 30(1):185-96. DOI: 10.1002/1521-4141(200001)30:1<185::AID-IMMU185>3.0.CO;2-L. View

Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel R . Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med. 1998; 188(8):1493-501. PMC: 2213416. DOI: 10.1084/jem.188.8.1493. View

10.

Freigang S, Eschli B, Harris N, Geuking M, Quirin K, Schrempf S . A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8(+) T cell responses. Proc Natl Acad Sci U S A. 2007; 104(33):13426-31. PMC: 1948914. DOI: 10.1073/pnas.0704423104. View

11.

Ludewig B, Ochsenbein A, Odermatt B, Paulin D, Hengartner H, Zinkernagel R . Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med. 2000; 191(5):795-804. PMC: 2195849. DOI: 10.1084/jem.191.5.795. View

12.

Freigang S, Egger D, Bienz K, Hengartner H, Zinkernagel R . Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming. Proc Natl Acad Sci U S A. 2003; 100(23):13477-82. PMC: 263839. DOI: 10.1073/pnas.1835685100. View